Mimicrete
PrivateLast Round
Grant
Nov 1, 2025
Total Funding Raised
$1.32M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mimicrete operates in Frontier & Industrial Tech and is based in Cambridge. Its latest recorded funding round was a Grant round in November 2025.
Mimicrete is a materials science company that develops biomimetic self-healing concrete technologies designed to reduce costs and carbon emissions in the construction industry.
Sector
Frontier & Industrial Tech
Verticals
Construction Tech, Advanced Materials, Green Building, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mimicrete Comparables
Compare Mimicrete with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Basilisk Self-Healing Concrete | 83% | |
| DMAT | 82% | |
| Material Evolution | 73% |
For institutional investors. Book with your work email.
Mimicrete Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2025 | ||||
| Accelerator | Sep 15, 2025 | ||||
| Seed | Sep 15, 2025 | ||||
| Accelerator | Jun 12, 2024 | ||||
| Accelerator | Oct 13, 2023 | ||||
Grant | May 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mimicrete Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Henry Royce Institute | Grant, Seed |
| Sands VC | Grant, Seed |
| Vest Coast Capital | Pre Seed, Grant |
| Morgan Stanley Inclusive & Sustainable Ventures | Seed |
| Innovate UK | Grant |
| Morgan Stanley Inclusive Ventures Lab | Grant, Accelerator |
| Village Capital | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2025
Received grant funding from Innovate UK and other investors.
- Sep 15, 2025
$340K round led by Henry Royce Institute
For institutional investors. Book with your work email.
Mimicrete Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mimicrete's valuation, stock price, and market status.
Is Mimicrete a public or private company?
Mimicrete is a private company.
What is the current stock price of Mimicrete?
Mimicrete is a private company, so its shares have no public market price. Caplight tracks Mimicrete's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mimicrete worth (valuation)?
Valuation information for Mimicrete is not publicly available.
Can I buy Mimicrete stock?
Mimicrete shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mimicrete's last funding round?
Mimicrete's most recent funding round was Grant on November 1, 2025.
Who are the main investors in Mimicrete?
Key investors in Mimicrete include Henry Royce Institute, Innovate UK, Morgan Stanley Inclusive Ventures Lab, Deeptech Labs.
Will Mimicrete IPO soon?
No public IPO plans have been announced for Mimicrete.
How can I track Mimicrete secondary market activity?
Caplight tracks bids, offers, and trades in Mimicrete's shares on secondary markets.